Oruka Therapeutics, Inc. - ORKA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | VIKING GLOBAL INVESTORS LP | 2.5% | 1,503,478 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Parent GP LLC | 2.5% | 1,503,478 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities GP LLC | 1.5% | 902,087 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Portfolio GP LLC | 1.5% | 902,087 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Illiquid Investments Sub-Master LP | 1.5% | 902,087 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown GP LLC | 1.0% | 601,391 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown Portfolio GP LLC | 1.0% | 601,391 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown (Aggregator) LP | 1.0% | 601,391 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | HALVORSEN OLE ANDREAS | 2.5% | 1,503,478 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Shabet Rose Sharon | 2.5% | 1,503,478 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 7.4% | 4,556,952 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 7.4% | 4,556,952 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 7.4% | 4,556,952 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | VHCP Management III, LLC | 7.4% | 4,556,952 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | VHCP Management EG, LLC | 7.4% | 4,556,952 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Nimish Shah | 7.4% | 4,556,952 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Bong Y. Koh | 7.4% | 4,556,952 | View |
| Aug 14, 2026 | SCHEDULE 13G | RTW Investments, LP | 5.2% | 3,139,030 | View |
| Aug 14, 2026 | SCHEDULE 13G | Roderick Wong | 5.2% | 3,139,030 | View |
| Aug 12, 2026 | SCHEDULE 13G | Capital World Investors | 5.6% | 3,401,639 | View |
| Jul 01, 2026 | SCHEDULE 13D/A | — | 9.99% | — | View |
| May 15, 2026 | SCHEDULE 13G/A | VIKING GLOBAL INVESTORS LP | 5.3% | 2,666,690 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Parent GP LLC | 5.3% | 2,666,690 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities GP LLC | 3.2% | 1,600,014 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Portfolio GP LLC | 3.2% | 1,600,014 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Illiquid Investments Sub-Master LP | 3.2% | 1,600,014 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown GP LLC | 2.1% | 1,066,676 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown Portfolio GP LLC | 2.1% | 1,066,676 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown (Aggregator) LP | 2.1% | 1,066,676 | View |
| May 15, 2026 | SCHEDULE 13G/A | HALVORSEN OLE ANDREAS | 5.3% | 2,666,690 | View |
| May 15, 2026 | SCHEDULE 13G/A | Shabet Rose Sharon | 5.3% | 2,666,690 | View |
| May 04, 2026 | SCHEDULE 13D/A | — | 9.99% | — | View |
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.